Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol
- 1 January 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 290 (1), C183-C188
- https://doi.org/10.1152/ajpcell.00199.2005
Abstract
Through specific cleavage of proteins that bind and inhibit insulin-like growth factor-I (IGF-I), pregnancy-associated plasma protein-A (PAPP-A) enhances local IGF-I availability, and, consequently, receptor activation. PAPP-A expression is increased in experimental models of vascular injury and in human atherosclerotic plaque; however, little is known about the regulation of PAPP-A gene expression in vascular cells. In this study, we tested the hypothesis that proinflammatory cytokines involved in the vascular injury response stimulate PAPP-A gene expression in human coronary artery smooth muscle cells (hCASMC) in culture. Tumor necrosis factor (TNF)-α and interleukin (IL)-1β stimulated PAPP-A gene expression in a time- and dose-dependent manner. The effect of these cytokines appears to be at the level of transcription because actinomycin D completely prevented the induction of PAPP-A gene expression. Accumulation of PAPP-A in cell-conditioned medium paralleled mRNA synthesis, as did proteolytic activity against IGF binding protein-4 (IGFBP-4). Interestingly, pretreatment of hCASMC with resveratrol, a polyphenol found in the skin of grapes and in red wine purported to underlie the “French paradox,” inhibited TNF-α- and IL-1β-induced PAPP-A expression and, hence, its IGFBP-4 proteolytic activity. Resveratrol had no effect on basal PAPP-A expression and protease activity. Our finding that PAPP-A gene expression in hCASMC is stimulated by TNF-α and IL-1β suggests a mechanism for the regulation of PAPP-A in response to vascular injury that may contribute to the enhanced IGF-I bioactivity in intimal hyperplasia and atherosclerotic plaque development. Our results also suggest that PAPP-A may be a target of the cardiovascular system-protective effects of resveratrol.Keywords
This publication has 45 references indexed in Scilit:
- Transforming Growth Factor-β Regulation of the Insulin-Like Growth Factor Binding Protein-4 Protease System in Cultured Human OsteoblastsJournal of Bone and Mineral Research, 2003
- Cell Surface Targeting of Pregnancy-associated Plasma Protein A Proteolytic ActivityJournal of Biological Chemistry, 2002
- Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysisBiochemical Journal, 2002
- Molecular Regulation of the IGF-Binding Protein-4 Protease System in Human Fibroblasts: Identification of a Novel Inducible InhibitorEndocrinology, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Pregnancy-Associated Plasma Protein-A Accounts for the Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Proteolytic Activity in Human Pregnancy Serum and Enhances the Mitogenic Activity of IGF by Degrading IGFBP-4 in VitroJournal of Clinical Endocrinology & Metabolism, 2001
- Increased Matrix Metalloproteinase-9 Activity in Unstable Carotid PlaquesStroke, 2000
- Suppression of nitric oxide synthase and the down‐regulation of the activation of NFκB in macrophages by resveratrolBritish Journal of Pharmacology, 1999
- Nuclear factor-κB activity and arterial response to balloon injuryAtherosclerosis, 1997